Cancer Antigen 125
- PMID: 32965916
- Bookshelf ID: NBK562245
Cancer Antigen 125
Excerpt
Cancer antigen 125 (CA125) is an antigenic tumor marker expressed by epithelial ovarian neoplasms and cells lining various organs such as the endometrium, fallopian tubes, pleura, peritoneum, and pericardium. CA125 is used as one of the serological tests in cases when an ovarian neoplasm is suspected and for monitoring patients who have already been diagnosed with epithelial ovarian cancers. However, due to its low sensitivity, the test has limited use in diagnosing early ovarian cancer. The specificity is particularly low in premenopausal women; thus, it is most useful in postmenopausal women.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
- Introduction
- Etiology and Epidemiology
- Pathophysiology
- Specimen Requirements and Procedure
- Diagnostic Tests
- Testing Procedures
- Interfering Factors
- Results, Reporting, and Critical Findings
- Clinical Significance
- Quality Control and Lab Safety
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
References
-
- Jacobs I, Bast RC. The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod. 1989 Jan;4(1):1-12. - PubMed
-
- American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology. Practice Bulletin No. 174: Evaluation and Management of Adnexal Masses. Obstet Gynecol. 2016 Nov;128(5):e210-e226. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous